210 related articles for article (PubMed ID: 28941798)
41. Direct inhibition of Re Du Ning Injection and its active compounds on human liver cytochrome P450 enzymes by a cocktail method.
Kang D; Geng T; Lian Y; Li Y; Ding G; Huang W; Ma S; Wang Z; Ma Z; Xiao W
Biomed Chromatogr; 2017 Jul; 31(7):. PubMed ID: 27891633
[TBL] [Abstract][Full Text] [Related]
42. Potential beneficial metabolic interactions between tamoxifen and isoflavones via cytochrome P450-mediated pathways in female rat liver microsomes.
Chen J; Halls SC; Alfaro JF; Zhou Z; Hu M
Pharm Res; 2004 Nov; 21(11):2095-104. PubMed ID: 15587933
[TBL] [Abstract][Full Text] [Related]
43.
Zhang X; Feng P; Gao X; Wang B; Gou C; Bian R
Pharm Biol; 2020 Dec; 58(1):247-252. PubMed ID: 32223485
[No Abstract] [Full Text] [Related]
44. Studies on the cytochrome P450 (CYP)-mediated metabolic properties of miocamycin: evaluation of the possibility of a metabolic intermediate complex formation with CYP, and identification of the human CYP isoforms.
Kasahara M; Suzuki H; Komiya I
Drug Metab Dispos; 2000 Apr; 28(4):409-17. PubMed ID: 10725309
[TBL] [Abstract][Full Text] [Related]
45. High-Throughput Cytochrome P450 Cocktail Inhibition Assay for Assessing Drug-Drug and Drug-Botanical Interactions.
Li G; Huang K; Nikolic D; van Breemen RB
Drug Metab Dispos; 2015 Nov; 43(11):1670-8. PubMed ID: 26285764
[TBL] [Abstract][Full Text] [Related]
46. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes.
Yao HT; Chang YW; Lan SJ; Chen CT; Hsu JT; Yeh TK
Life Sci; 2006 Nov; 79(26):2432-40. PubMed ID: 16978661
[TBL] [Abstract][Full Text] [Related]
47. Inhibitory effects of curcumin on activity of cytochrome P450 2C9 enzyme in human and 2C11 in rat liver microsomes.
Wang Z; Sun W; Huang CK; Wang L; Xia MM; Cui X; Hu GX; Wang ZS
Drug Dev Ind Pharm; 2015 Apr; 41(4):613-6. PubMed ID: 24517573
[TBL] [Abstract][Full Text] [Related]
48. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).
Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M
J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892
[TBL] [Abstract][Full Text] [Related]
49. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
50. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
Wei J; Zhang H; Zhao Q
Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094
[TBL] [Abstract][Full Text] [Related]
51. In vitro Inhibitory Effects of Isofraxidin on Human Liver Cytochrome P450 Enzymes.
Song X; Dong G; Zhou Y
Pharmacology; 2019; 103(3-4):120-127. PubMed ID: 30544127
[TBL] [Abstract][Full Text] [Related]
52. In vitro biotransformation of atrazine by rat liver microsomal cytochrome P450 enzymes.
Hanioka N; Jinno H; Kitazawa K; Tanaka-Kagawa T; Nishimura T; Ando M; Ogawa K
Chem Biol Interact; 1998 Nov; 116(3):181-98. PubMed ID: 9920461
[TBL] [Abstract][Full Text] [Related]
53. Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes.
Guo Z; Raeissi S; White RB; Stevens JC
Drug Metab Dispos; 1997 Mar; 25(3):390-3. PubMed ID: 9172960
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions.
Ohyama K; Nakajima M; Suzuki M; Shimada N; Yamazaki H; Yokoi T
Br J Clin Pharmacol; 2000 Mar; 49(3):244-53. PubMed ID: 10718780
[TBL] [Abstract][Full Text] [Related]
55. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction.
Wang Y; Jiang YM; Wang YT; Kang JW; Yu T; Zhao HY; Bian BL; Huang M; Bi HC
J Ethnopharmacol; 2014 Oct; 156():175-81. PubMed ID: 25219605
[TBL] [Abstract][Full Text] [Related]
56. Effect of antifungal drugs on cytochrome P450 (CYP) 1A2, CYP2D6, and CYP2E1 activities in human liver microsomes.
Niwa T; Inoue-Yamamoto S; Shiraga T; Takagi A
Biol Pharm Bull; 2005 Sep; 28(9):1813-6. PubMed ID: 16141569
[TBL] [Abstract][Full Text] [Related]
57. [Inhibitory effects of astragaloside IV on cytochrome P450 enzyme of rat liver microsomes].
Shan W; Zhang Y; Zhu J; Shao Q; Fan X
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):85-8. PubMed ID: 22741468
[TBL] [Abstract][Full Text] [Related]
58. Effect of single-walled carbon nanotubes on cytochrome P450 activity in human liver microsomes in vitro.
Asai Y; Sakakibara Y; Inoue R; Inoue R; Nadai M; Katoh M
Biopharm Drug Dispos; 2018 May; 39(5):275-279. PubMed ID: 29719052
[TBL] [Abstract][Full Text] [Related]
59. Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes.
Zhang JW; Liu Y; Li W; Hao DC; Yang L
Eur J Clin Pharmacol; 2006 Jul; 62(7):497-502. PubMed ID: 16645869
[TBL] [Abstract][Full Text] [Related]
60. Interaction of antitumor platinum complexes with human liver microsomal cytochromes P450.
Masek V; Anzenbacherová E; Machová M; Brabec V; Anzenbacher P
Anticancer Drugs; 2009 Jun; 20(5):305-11. PubMed ID: 19378397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
